Company: HCTI
Filing Date: 2025-04-22
Form Type: S-1/A
Source: 0001213900-25-034248
Chunk: 17

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-22
Form: S-1/A
Chunk 17
---
 results of operations, and future financial performance.

Factors or events that could cause our actual
results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results,
levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States,
we do not intend to update any of the forward-looking statements to conform these statements to actual results.

<div align='center'>6

USE OF PROCEEDS</div>

This prospectus relates to the Common Stock
that may be offered and sold from time to time by the selling stockholders. We are not selling any shares of our Common Stock in this
offering, and we will not receive any of the proceeds from the sale of shares of our Common Stock by the selling stockholder. The selling
stockholders will receive all of the proceeds from any sales of the shares of our Common Stock offered hereby, however we will receive
the proceeds from any cash exercises of the Purchase Warrants; however as a result of the zero exercise price option we do not expect
to receive any cash proceeds from the exercise of the Series B Warrants.

<div align='center'>7

DIVIDEND POLICY</div>

We have never declared or paid any cash dividend
and do not anticipate paying any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance
operations and expand our business. Our board of directors has sole discretion whether to pay dividends. If our board of directors decides
to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus,
general financial condition, contractual restrictions and other factors that our directors may deem relevant.

<div align='center'>THE PRIVATE PLACEMENT</div>

On February 27, 2025, we entered
into Securities Purchase Agreements with the selling stockholders for the private placement of 36,190,485 Units, each Unit consisting
of (i) one share of Common Stock; (ii) a Pre-Funded Warrant to purchase one share of common stock; a Series A Warrant to purchase one
share of common stock and one Series B Warrant to purchase one share of common stock at an offering price of $0.42 per Unit (or $0.41999
per Unit in the case of Units that include pre-funded warrants). The Common Stock, the Pre-Funded Warrants and the Purchase Warrants included